Table 4.

The heterogeneity test of diverse fatty acids (FAs) genetic variants in inflammatory bowel disease (IBD) Genome-wide summary association study (GWAS) datasets.

Traits (Outcome)	Fat Acids (Exposure)	Methods	Q	Q-dif	p
CD	total FA	MR Egger	13.249	12	0.351
		IVW	18.072	13	0.155
	saturated FA	MR Egger	51.622	21	2.160 × 10−4
		IVW	52.196	22	2.937 × 10−3
	polyunsaturated FA	MR Egger	20.667	17	0.242
		IVW	22.130	18	0.226
	monounsaturated FA	MR Egger	58.748	17	1.688 × 10−6
		IVW	62.658	18	7.558 × 10−7
	Omega-3 FA	MR Egger	51.832	19	7.012 × 10−5
		IVW	52.060	20	1.116 × 10−4
	Omega-6 FA	MR Egger	14.321	12	0.281
		IVW	14.452	13	0.343
UC	total FA	MR Egger	15.198	12	0.231
		IVW	15.579	13	0.273
	saturated FA	MR Egger	44.057	21	2.299 × 10−3
		IVW	47.138	22	1.408 × 10−3
	polyunsaturated FA	MR Egger	42.533	17	5.614 × 10−4
		IVW	44.869	18	4.328 × 10−4
	monounsaturated FA	MR Egger	35.630	17	5.13 × 10−3
		IVW	35.670	18	7.78 × 10−3
	Omega-3 FA	MR Egger	24.271	19	0.186
		IVW	26.541	20	0.149
	Omega-6 FA	MR Egger	22.678	12	0.031
		IVW	26.945	13	0.013

p < 0.05 is set as the significant threshold.